FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3

Journal of Neurochemistry

Volumn 113, Issue 4, 2010, Pages 836-847

  Konstantoulas, Constantine James ^a   Parmar, Malin ^b   Li, Meng ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Forkhead box P1; Midbrain dopaminergic neurons; Paired like homeodomain transcription factor 3; Transcription

Indexed keywords

DOPAMINE; LUCIFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR PITX3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEVELOPMENT; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; IN VITRO STUDY; MESENCEPHALON; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DOPAMINE; EMBRYONIC STEM CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; MICE; NEURONS; PROMOTER REGIONS, GENETIC; RATS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRESSOR PROTEINS; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS; TRANSFECTION;

MAMMALIA;

EID: 77950941894     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06650.x     Document Type: Article

References (82)

1. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T. Ericson J. (2006) Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124, 393 405.
2. Ang S. L. (2006) Transcriptional control of midbrain dopaminergic neuron development. Development 133, 3499 3506.
3. Azuara V., Perry P., Sauer S. et al. (2006) Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532 538.
4. Bernstein B. E., Mikkelsen T. S., Xie X. et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315 326.
5. Bjorklund A. Lindvall O. (1984) Dopamine-containing systems in the CNS, in Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS, Vol. 2 (Bjorklund A. Hokfelt T., eds), pp. 55 121. Elsevier
6. Bohlen und H. O., Schober A. Krieglstein K. (2004) Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog. Neurobiol. 73, 151 177.
7. Boyer L. A., Plath K., Zeitlinger J. et al. (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349 353.
8. Brundin P., Isacson O. Bjorklund A. (1985) Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331, 251 259.
9. Carlsson P. Mahlapuu M. (2002) Forkhead transcription factors: key players in development and metabolism. Dev. Biol. 250, 1 23.
10. Cazorla P., Smidt M. P., O'Malley K. L. Burbach J. P. (2000) A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J. Neurochem. 74, 1829 1837.
11. Chung S., Hedlund E., Hwang M., Kim D. W., Shin B. S., Hwang D. Y., Jung K. U., Isacson O. Kim K. S. (2005) The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol. Cell. Neurosci. 28, 241 252.
12. Chung S., Shin B. S., Hwang M., Lardaro T., Kang U. J., Isacson O. Kim K. S. (2006) Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24, 1583 1593.
13. Dailly E., Chenu F., Renard C. E. Bourin M. (2004) Dopamine, depression and antidepressants. Fundam. Clin. Pharmacol. 18, 601 607.
14. Dasen J. S., De Camilli A., Wang B., Tucker P. W. Jessell T. M. (2008) Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 134, 304 316.
15. Dunnett S. B. Bjorklund A. (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399, A32 A39.
16. Dunnett S. B., Bjorklund A. Lindvall O. (2001) Cell therapy in Parkinson's disease - stop or go? Nat. Rev. Neurosci. 2, 365 369. (Pubitemid 33680578)
17. Fahn S. (2003) Description of Parkinson's disease as a clinical syndrome. Ann. N Y Acad. Sci. 991, 1 14.
18. Fearnley J. M. Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (Pt 5 2283 2301.
19. Ferri A. L., Lin W., Mavromatakis Y. E., Wang J. C., Sasaki H., Whitsett J. A. Ang S. L. (2007) Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 134, 2761 2769.
20. Hu H., Wang B., Borde M., Nardone J., Maika S., Allred L., Tucker P. W. Rao A. (2006) Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7, 819 826.
21. Hudson J. L., Bickford P., Johansson M., Hoffer B. J. Stromberg I. (1994) Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation. J. Neurosci. 14, 283 290.
22. Hwang D. Y., Ardayfio P., Kang U. J., Semina E. V. Kim K. S. (2003) Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res. Mol. Brain Res. 114, 123 131.
23. Jepsen K., Gleiberman A. S., Shi C., Simon D. I. Rosenfeld M. G. (2008) Cooperative regulation in development by SMRT and FOXP1. Genes Dev. 22, 740 745.
24. Jorgensen H. F., Giadrossi S., Casanova M., Endoh M., Koseki H., Brockdorff N. Fisher A. G. (2006) Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cells. Cell Cycle 5, 1411 1414.
25. Kaufmann E. Knochel W. (1996) Five years on the wings of fork head. Mech. Dev. 57, 3 20.
26. Kelley A. E. Berridge K. C. (2002) The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22, 3306 3311.
27. Kim J. Y., Koh H. C., Lee J. Y. et al. (2003) Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J. Neurochem. 85, 1443 1454.
28. Kittappa R., Chang W. W., Awatramani R. B. McKay R. D. (2007) The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol. 5, e325.
29. Klockgether T. (2004) Parkinson's disease: clinical aspects. Cell Tissue Res. 318, 115 120.
30. Lang A. E. Lozano A. M. (1998) Parkinson's disease. Second of two parts. N. Engl. J. Med. 339, 1130 1143.
31. Lebel M., Gauthier Y., Moreau A. Drouin J. (2001) Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site. J. Neurochem. 77, 558 567.
32. Lee S. H., Lumelsky N., Studer L., Auerbach J. M. McKay R. D. (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18, 675 679.
33. Lee T. I., Jenner R. G., Boyer L. A. et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301 313.
34. Lehmann O. J., Sowden J. C., Carlsson P., Jordan T. Bhattacharya S. S. (2003) Fox's in development and disease. Trends Genet. 19, 339 344.
35. Li C. Tucker P. W. (1993) DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc. Natl Acad. Sci. USA 90, 11583 11587.
36. Lin W., Metzakopian E., Mavromatakis Y. E. et al. (2009) Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development. Dev. Biol. 333, 386 396.
37. Lindvall O. Hagell P. (2000) Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 127, 299 320.
38. Liu S., Tian Z., Yin F., Zhao Q. Fan M. (2009) Generation of dopaminergic neurons from human fetal mesencephalic progenitors after co-culture with striatal-conditioned media and exposure to lowered oxygen. Brain Res. Bull. 80, 62 68.
39. Maxwell S. L., Ho H. Y., Kuehner E., Zhao S. Li M. (2005) Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev. Biol. 282, 467 479.
40. Messmer K., Remington M. P., Skidmore F. Fishman P. S. (2007) Induction of tyrosine hydroxylase expression by the transcription factor Pitx3. Int. J. Dev. Neurosci. 25, 29 37.
41. Milosevic J., Brandt A., Roemuss U., Arnold A., Wegner F., Schwarz S. C., Storch A., Zimmermann H. Schwarz J. (2006) Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling. J. Neurochem. 99, 913 923.
42. Nunes I., Tovmasian L. T., Silva R. M., Burke R. E. Goff S. P. (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl Acad. Sci. USA 100, 4245 4250.
43. Okita K., Nakagawa M., Hyenjong H., Ichisaka T. Yamanaka S. (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949 953.
44. Olanow C. W., Kordower J. H. Freeman T. B. (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102 109.
45. Overdier D. G., Porcella A. Costa R. H. (1994) The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol. Cell. Biol. 14, 2755 2766.
46. Park I. H., Lerou P. H., Zhao R., Huo H. Daley G. Q. (2008) Generation of human-induced pluripotent stem cells. Nat. Protoc. 3, 1180 1186.
47. Parmar M. Li M. (2007) Early specification of dopaminergic phenotype during ES cell differentiation. BMC Dev. Biol. 7, 86.
48. Pierrou S., Hellqvist M., Samuelsson L., Enerback S. Carlsson P. (1994) Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J. 13, 5002 5012.
49. Prakash N. Wurst W. (2006a) Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63, 187 206.
50. Prakash N. Wurst W. (2006b) Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol. 575, 403 410.
51. Redmond D. E. Jr., Sladek J. R. Spencer D. D. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 345, 146 147.
52. Rousso D. L., Gaber Z. B., Wellik D., Morrisey E. E. Novitch B. G. (2008) Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron 59, 226 240.
53. Roux J., Pictet R. Grange T. (1995) Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol. 14, 385 396.
54. Sabolek M., Baumann B., Heinrich M. et al. (2009) Initiation of dopaminergic differentiation of Nurr1(-) mesencephalic precursor cells depends on activation of multiple mitogen-activated protein kinase pathways. Stem Cells 27, 2009 2021.
55. Saucedo-Cardenas O., Quintana-Hau J. D., Le W. D., Smidt M. P., Cox J. J., De Mayo F., Burbach J. P. Conneely O. M. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl Acad. Sci. USA 95, 4013 4018.
56. Semina E. V., Murray J. C., Reiter R., Hrstka R. F. Graw J. (2000) Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum. Mol. Genet. 9, 1575 1585.
57. Sesack S. R. Carr D. B. (2002) Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol. Behav. 77, 513 517.
58. Shi C., Zhang X., Chen Z., Sulaiman K., Feinberg M. W., Ballantyne C. M., Jain M. K. Simon D. I. (2004) Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J. Clin. Invest. 114, 408 418.
59. Shi C., Sakuma M., Mooroka T. et al. (2008) Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 112, 4699 4711.
60. Shu W., Yang H., Zhang L., Lu M. M. Morrisey E. E. (2001) Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 276, 27488 27497.
61. Simon H. H., Bhatt L., Gherbassi D., Sgado P. Alberi L. (2003) Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann. N Y Acad. Sci. 991, 36 47.
62. Smidt M. P. Burbach J. P. (2007) How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8, 21 32.
63. Smidt M. P., van Schaick H. S., Lanctot C., Tremblay J. J., Cox J. J., van der Kleij A. A., Wolterink G., Drouin J. Burbach J. P. (1997) A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl Acad. Sci. USA 94, 13305 13310.
64. Smidt M. P., Asbreuk C. H., Cox J. J., Chen H., Johnson R. L. Burbach J. P. (2000) A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3, 337 341.
65. Smidt M. P., Smits S. M., Bouwmeester H., Hamers F. P., van der Linden A. J., Hellemons A. J., Graw J. Burbach J. P. (2004) Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131, 1145 1155.
66. Smits S. M., Ponnio T., Conneely O. M., Burbach J. P. Smidt M. P. (2003) Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18, 1731 1738.
67. Sonntag K. C., Simantov R., Kim K. S. Isacson O. (2004) Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur. J. Neurosci. 19, 1141 1152.
68. Storch A., Paul G., Csete M., Boehm B. O., Carvey P. M., Kupsch A. Schwarz J. (2001) Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170, 317 325.
69. Storch A., Lester H. A., Boehm B. O. Schwarz J. (2003) Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J. Chem. Neuroanat. 26, 133 142.
70. Takahashi K. Yamanaka S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663 676.
71. Thompson L., Barraud P., Andersson E., Kirik D. Bjorklund A. (2005) Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25, 6467 6477.
72. Ungless M. A. (2004) Dopamine: the salient issue. Trends Neurosci. 27, 702 706.
73. van den M. P., Luk K. C., Ste-Marie L., Montgomery J., Blanchet P. J., Sadikot A. F. Drouin J. (2003) Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130, 2535 2542.
74. Wallen A. Perlmann T. (2003) Transcriptional control of dopamine neuron development. Ann. N Y Acad. Sci. 991, 48 60.
75. Wallen A. A., Castro D. S., Zetterstrom R. H., Karlen M., Olson L., Ericson J. Perlmann T. (2001) Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 18, 649 663.
76. Wang B., Lin D., Li C. Tucker P. (2003) Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278, 24259 24268.
77. Wei Y., Harris T. Childs G. (2002) Global gene expression patterns during neural differentiation of P19 embryonic carcinoma cells. Differentiation 70, 204 219. (Pubitemid 38230555)
78. Wernig M., Zhao J. P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O. Jaenisch R. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856 5861.
79. Wightman R. M. Robinson D. L. (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82, 721 735.
80. Ying Q. L. Smith A. G. (2003) Defined conditions for neural commitment and differentiation. Methods Enzymol. 365, 327 341.
81. Ying Q. L., Stavridis M., Griffiths D., Li M. Smith A. (2003) Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183 186.
82. Zhao S., Maxwell S., Jimenez-Beristain A., Vives J., Kuehner E., Zhao J., O'Brien C., de Felipe C., Semina E. Li M. (2004) Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 19, 1133 1140.